Nabumetone
- Product NDC
- 60760-185
- 11-digit product format
- 607600185
- Labeler code
- 60760
- Product ID
- 60760-185_7abccdde-91b3-3247-e053-2991aa0a77c5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA075280
- Marketing category
- ANDA
- Marketing start
- 2018-04-27
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-185-14 | 60760018514 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-185-14) | 14 tablet | 2018-05-30 | 0000-00-00 | No | No | Current |
| 60760-185-20 | 60760018520 | 20 TABLET in 1 BOTTLE, PLASTIC (60760-185-20) | 20 tablet | 2018-04-27 | 0000-00-00 | No | No | Current |
| 60760-185-60 | 60760018560 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-185-60) | 60 tablet | 2018-04-27 | 0000-00-00 | No | No | Current |